Drug Type Small molecule drug |
Synonyms DDA, diflorasone, Diflorasone diacetate (JP17/USP) + [7] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (14 Sep 1977), |
Regulation- |
Molecular FormulaC26H32F2O7 |
InChIKeyBOBLHFUVNSFZPJ-JOYXJVLSSA-N |
CAS Registry33564-31-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01327 | Diflorasone Diacetate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Amyloidosis | Japan | 16 Apr 1985 | |
Dermatitis | Japan | 16 Apr 1985 | |
Drug Eruptions | Japan | 16 Apr 1985 | |
Eczema | Japan | 16 Apr 1985 | |
Erythema | Japan | 16 Apr 1985 | |
Gottron syndrome | Japan | 16 Apr 1985 | |
Granuloma | Japan | 16 Apr 1985 | |
Insect Bites and Stings | Japan | 16 Apr 1985 | |
Keloid | Japan | 16 Apr 1985 | |
Lupus Erythematosus | Japan | 16 Apr 1985 | |
Lymphoma | Japan | 16 Apr 1985 | |
Pemphigoid, Bullous | Japan | 16 Apr 1985 | |
Pemphigus | Japan | 16 Apr 1985 | |
Pigmented Purpuric Eruption | Japan | 16 Apr 1985 | |
Pityriasis Rubra Pilaris | Japan | 16 Apr 1985 | |
Prurigo | Japan | 16 Apr 1985 | |
Psoriasis | Japan | 16 Apr 1985 | |
Skin Diseases | United States | 14 Sep 1977 |